News | May 8, 2026
A recent study by Tatyana Avilova, Economist at Secretariat has been selected by the Editor of JAMA Health Forum as an Editor’s Choice: Clinical Trial of 2025.
May 13, 2026
Dr. McLean brings industry‑leading biomechanics and wearable technology expertise to Secretariat, strengthening the firm’s ability to address complex, technology‑driven disputes.
Secretariat is pleased to welcome Dr. Scott McLean as a Managing Director to our growing Engineering Sciences practice. A leading global expert in biomechanics and wearable technology, Dr. McLean brings more than two decades of experience in applying these unique skills to advise and support high-profile large-scale clients in developing, integrating, and applying various technology solutions to better understand and enhance human health, wellness, and performance.
Dr. McLean regularly provides expert testimony and advisory support across product liability, sports and fitness equipment, and wearable technology intellectual property disputes, primarily involving patents and trade secrets. In his work, Dr. McLean draws on deep industry expertise spanning 3‑D motion capture, wearable sensors, medical imaging, cadaveric and mechanical testing, computational modeling, and artificial intelligence (AI), enabling him to conduct rigorous evaluations of user‑product interactions under both laboratory and real‑world conditions.
A recognized leader in his field, Dr. McLean has developed innovative biomechanical techniques that integrate sensing and AI technologies to help clients assess product performance, analyze user behaviors, and evaluate risk in real-world use-case settings. Beyond litigation, Dr. McLean advises clients in the military, pharmaceutical, and digital health sectors on the development, validation, and deployment of wearable technologies to monitor and predict personalized health, wellness, and performance outcomes for these unique populations. He also advises technology development and technology integration clients on how to best navigate growing data accuracy and reliability, legal, and regulatory challenges as wearable technologies transition from consumer products to more targeted medical monitoring devices.
“I’ve known Scott for many years, and the impact of his work in the biomechanics and wearable technology industries has been truly exceptional,” said Eric Guyer, Managing Director. “He brings a tremendous depth of expertise, intellectual rigor, and a thoughtful approach to all he does. I’m genuinely excited to welcome him to Secretariat and for our clients to benefit from his leadership.”
Before joining Secretariat, Dr. McLean served as a Principal at a multinational engineering and scientific consulting firm. He was previously Director of Innovation Research at Fitbit, where he played a key role in bringing multiple wearable products to market globally, and a Professor at the University of Michigan working extensively with high-profile sports and military sectors. Earlier in his career, he held research and leadership roles at the Cleveland Clinic.
Dr. McLean earned his PhD in Orthopedic Biomechanics from the University of Queensland in Australia, and obtained his MSc in Biomechanics from the same university. He holds a distinguished research record that includes more than 60 peer-reviewed publications, more than 100 conference presentations, and more than $7 million in federal and private funding to support his research. He also brings exceptional academic and industry credibility, having held senior leadership roles within the American College of Sports Medicine, the International Society of Biomechanics, and the Consumer Technology Association—where he helped shape actionable standards for the development and evaluation of wearable health technologies.
A recent study by Tatyana Avilova, Economist at Secretariat has been selected by the Editor of JAMA Health Forum as an Editor’s Choice: Clinical Trial of 2025.
Secretariat Experts Recognized in Lexology’s 2026 Investigations Report
Ten of Secretariat experts have been recognized in the Lexology Index 2026 Investigations report, produced in partnership with Global Investigations Review. The guide highlights leading investigations lawyers, digital forensic specialists, and forensic accountants who are trusted to support the most demanding matters worldwide.
AI is rapidly reshaping how financial institutions in Latin America approach compliance, shifting from reactive monitoring to proactive financial crime detection. Advanced AI platforms specialized in crime detection enable banks to process vast datasets, identify anomalous behaviors, and map hidden relationships across accounts and jurisdictions. This is particularly relevant in a region characterized by complex cross-border flows, uneven regulatory enforcement, and significant exposure to illicit economies.